Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Axitinib × Gynecologic × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Blood Specimen Collection 29 Methods 22 Early Intervention, Educational 21 Colposcopy 21 Standard of Care 16 Cisplatin 16 Surveys and Questionnaires 15 Educational Status 15 Brachytherapy 15 Sentinel Lymph Node Biopsy 14 Exercise 14 Counseling 13 Therapeutics 12 Carboplatin 12 Magnetic Resonance Spectroscopy 11 Interviews as Topic 11 Biopsy 11 Surgical Procedures, Operative 10 Paclitaxel 10 Human Papillomavirus DNA Tests 10 Specimen Handling 9 Radiotherapy 9 Indocyanine Green 9 Behavior Therapy 9 Vaginal Smears 8 Radiotherapy, Intensity-Modulated 8 Psychiatric Rehabilitation 8 Papanicolaou Test 8 Palliative Care 8 Lymph Node Excision 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03826589 2025-06-11

ALARICE

The University of Hong Kong

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡